Labial tissue rejuvenation and sexual function improvement using a novel noninvasive focused monopolar radio frequency device.
Zeljka Clark
https://pubmed.ncbi.nlm.nih.gov/28853967Actively Recruiting
Led by Institut Investigacio Sanitaria Pere Virgili · Updated on 2026-04-16
34
Participants Needed
1
Research Sites
21 weeks
Total Duration
Researchers are evaluating the effectiveness of combined monopolar radiofrequency and ultrasound technology (BTL EXILIS Ultra 360) for treating dyspareunia, which is pain during sexual intercourse, caused by scarring after vaginal delivery. The study focuses on women of childbearing age who have experienced perineal trauma such as tears or episiotomies during childbirth. This non-randomized, quasi-experimental study aims to compare pain levels before and after treatment using a validated pain scale called the Visual Analogue Scale (VAS).
CONDITIONS
Effectiveness of Radiofrequency Combined With Ultrasound for the Treatment of Postpartum Dyspareunia
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 12 weeks
Participants receive up to three sessions of combined monopolar radiofrequency and ultrasound treatment using the BTL EXILIS Ultra 360™ device to reduce pain caused by postpartum scarring. After the first session, participants wait 4 to 6 weeks before the second session, followed by a pain assessment. If pain remains moderate to severe, a third session is offered, followed by a final assessment 4 to 6 weeks later.
2 to 3 treatment sessions and 2 to 3 follow-up assessments over 12 weeks
Total: 1 location
1
Centro Procrear
Tarragona, TARRAGONA, Spain, 43002
Actively Recruiting
L
LYS GARCIA VILAPLANA, Lead Researcher
C
CRISTINA REY REÑONES, DOCTORA
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Zeljka Clark
https://pubmed.ncbi.nlm.nih.gov/28853967Monique J Vanaman Wilson, Joanna Bolton, Isabela T Jones...
https://pubmed.ncbi.nlm.nih.gov/29701623Scott W Dunbar, David J Goldberg
https://pubmed.ncbi.nlm.nih.gov/26580871Yona Tadir, Adrian Gaspar, Ahinoam Lev-Sagie...
https://pubmed.ncbi.nlm.nih.gov/28220946Lisieux de Lourdes Martins Nóbrega Pessoa, Ayane Cristine Alves Sarmento, Kleyton Santos Medeiros...
https://pubmed.ncbi.nlm.nih.gov/36304041Melle A Spruijt, Wenche M Klerkx, Johannes C Kelder...
https://pubmed.ncbi.nlm.nih.gov/35362767Goran I Benic, Stefan P Bienz, Young Woo Song...
https://pubmed.ncbi.nlm.nih.gov/35191065M E Fernández-Cuadros, S G Kazlauskas, M J Albaladejo-Florin...
https://pubmed.ncbi.nlm.nih.gov/32441260E C Covington
https://pubmed.ncbi.nlm.nih.gov/11327428D Ashley Hill, Chantel A Taylor
https://pubmed.ncbi.nlm.nih.gov/33983001